Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS)
CNY 13.82
(0.0%)
CNY 13.82
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.07 Billion CNY | 1.93% |
| 2022 | 1.88 Billion CNY | 39.37% |
| 2021 | 1.35 Billion CNY | 36.38% |
| 2020 | 992.89 Million CNY | 41.31% |
| 2019 | 702.61 Million CNY | 13.23% |
| 2018 | 620.51 Million CNY | 15.95% |
| 2017 | 535.16 Million CNY | 26.77% |
| 2016 | 422.15 Million CNY | -10.15% |
| 2015 | 469.84 Million CNY | 30.49% |
| 2014 | 360.06 Million CNY | -10.33% |
| 2013 | 401.55 Million CNY | 17.03% |
| 2012 | 343.11 Million CNY | 18.86% |
| 2011 | 288.66 Million CNY | 10.89% |
| 2010 | 260.32 Million CNY | 34.01% |
| 2009 | 194.25 Million CNY | 15.35% |
| 2008 | 168.41 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 433.48 Million CNY | -10.07% |
| 2024 Q3 | 404.52 Million CNY | -6.68% |
| 2024 Q1 | 482.03 Million CNY | 100.3% |
| 2023 Q2 | 603.73 Million CNY | -6.56% |
| 2023 FY | 1.92 Billion CNY | 1.93% |
| 2023 Q3 | 549.11 Million CNY | -9.05% |
| 2023 Q4 | 240.65 Million CNY | -56.17% |
| 2023 Q1 | 646.13 Million CNY | 75.0% |
| 2022 Q1 | 485.72 Million CNY | 26.63% |
| 2022 FY | 1.88 Billion CNY | 39.37% |
| 2022 Q4 | 369.22 Million CNY | -23.12% |
| 2022 Q3 | 480.25 Million CNY | -13.01% |
| 2022 Q2 | 552.08 Million CNY | 13.66% |
| 2021 Q2 | 330.11 Million CNY | 23.4% |
| 2021 FY | 1.35 Billion CNY | 36.38% |
| 2021 Q3 | 372.91 Million CNY | 12.96% |
| 2021 Q4 | 383.58 Million CNY | 2.86% |
| 2021 Q1 | 267.51 Million CNY | -21.63% |
| 2020 Q1 | 153.77 Million CNY | -44.09% |
| 2020 Q3 | 225.98 Million CNY | -16.85% |
| 2020 Q4 | 341.34 Million CNY | 51.05% |
| 2020 FY | 992.89 Million CNY | 41.31% |
| 2020 Q2 | 271.79 Million CNY | 76.75% |
| 2019 Q1 | 112.97 Million CNY | -50.3% |
| 2019 FY | 702.61 Million CNY | 13.23% |
| 2019 Q4 | 275.04 Million CNY | 79.4% |
| 2019 Q3 | 153.31 Million CNY | -4.94% |
| 2019 Q2 | 161.28 Million CNY | 42.77% |
| 2018 Q1 | 169.91 Million CNY | 21.1% |
| 2018 FY | 620.51 Million CNY | 15.95% |
| 2018 Q4 | 227.28 Million CNY | 118.31% |
| 2018 Q3 | 104.11 Million CNY | -12.66% |
| 2018 Q2 | 119.2 Million CNY | -29.84% |
| 2017 Q4 | 140.3 Million CNY | -3.01% |
| 2017 Q2 | 127.72 Million CNY | 4.29% |
| 2017 Q1 | 122.47 Million CNY | 9.57% |
| 2017 Q3 | 144.66 Million CNY | 13.26% |
| 2017 FY | 535.16 Million CNY | 26.77% |
| 2016 Q1 | 102.42 Million CNY | -8.91% |
| 2016 FY | 422.15 Million CNY | -10.15% |
| 2016 Q4 | 111.77 Million CNY | -10.91% |
| 2016 Q3 | 125.46 Million CNY | 52.1% |
| 2016 Q2 | 82.48 Million CNY | -19.47% |
| 2015 Q2 | 128.64 Million CNY | 27.42% |
| 2015 Q1 | 100.95 Million CNY | -10.21% |
| 2015 FY | 469.84 Million CNY | 30.49% |
| 2015 Q4 | 112.44 Million CNY | -12.02% |
| 2015 Q3 | 127.79 Million CNY | -0.66% |
| 2014 Q1 | 86.27 Million CNY | -7.69% |
| 2014 FY | 360.06 Million CNY | -10.33% |
| 2014 Q2 | 86.87 Million CNY | 0.7% |
| 2014 Q4 | 112.43 Million CNY | 50.96% |
| 2014 Q3 | 74.48 Million CNY | -14.27% |
| 2013 Q3 | 94.71 Million CNY | 0.0% |
| 2013 FY | 401.55 Million CNY | 17.03% |
| 2013 Q4 | 93.46 Million CNY | -1.33% |
| 2012 FY | 343.11 Million CNY | 18.86% |
| 2011 FY | 288.66 Million CNY | 10.89% |
| 2010 FY | 260.32 Million CNY | 34.01% |
| 2009 FY | 194.25 Million CNY | 15.35% |
| 2008 FY | 168.41 Million CNY | 0.0% |